£200m backed, 60 founders in: inside Angel Academe's second EIS fund

Syndicate Room
Syndicate Room
June 22, 2026
5 min read

Last week Sarah Turner of Angel Academe joined SyndicateRoom's Francesca O'Brien to launch Angel Academe EIS Fund 2. If you couldn't make it, here's the recording — and below, the things I think are worth your time.

The problem hasn't moved — so the capital has to

Female-founded teams still take around 1.75% of the equity invested in the UK went to female-founded teams in 2025, it edged the wrong way. The average seed round is £500k for women against £3.7m for men; in AI it's £900k versus £6.5m. Sarah's point is the one I keep coming back to: this isn't a pipeline or quality problem. The gender index shows women-led businesses outperform those with solely male teams. It's a capital-allocation problem, and dedicated pools of capital are the way to fix it.

1.75% of the equity invested went to female-founded teams in 2025
UK data compiled by SyndicateRoom from Companies House

Ten years of evidence, not just intent

Angel Academe isn't new to this. Since 2014, they've backed 60 female-founded startups across 110 funding rounds, moving roughly £200m into female-founded businesses alongside their co-investors. Fund 1 (2025) invested in eight companies that have raised £10m+ between them and unlocked a £1m commitment from the British Business Bank to invest alongside the fund.

Two portfolio names stood out for me:

  • Béa Fertility — clinical-grade, non-invasive fertility care at a fraction of IVF cost. FDA-cleared, now live across all US states, first US pregnancies reported, and a signed term sheet for $8m from a US healthcare VC. Valuation up 8.4x since the 2020 round.

  • Zonova — technology that prevents hospital-acquired infections like sepsis and MRSA. Just closed a £2m pre-round, with health-tech VC Thena Capital joining the second phase.

Women won't deliver worse returns. The evidence, what little we have, points the other way.

What is Angel Academe EIS Fund 2?

Angel Academe EIS Fund 2 is raising up to £1.5m into 6–10 female-founded companies, targeting a 3x return. It's open from June to October 2026. You can read more about the fund on the deal page via the link below.

On the tax side, EIS still does the heavy lifting: 30% upfront income tax relief, loss relief that takes the effective capital at risk down to 38.5%, CGT exemption on gains, and IHT relief. You can carry relief back one year to 2025/26 (back only — there's no carry-forward). Worth noting: VCT relief has just dropped from 30% to 20%, while EIS holds at 30%. Tax treatment depends on individual circumstances and may be subject to change.

This is a high-risk asset class and returns aren't guaranteed — it suits part of a diversified portfolio. Consider your personal financial circumstances before investing, or speak to a registered financial or tax adviser.

Make an investment

You can register for Angel Academe EIS Fund 2 and make a commitment now without sending money — funds are only called near the close.

If you've got questions about the fund, the EIS timing, or how this fits your own situation, email tom@syndicateroom.com.

Award
Download your Angel Academe EIS Fund 2 brochure
The Angel Academe EIS Fund 2 is the UK's first fund focused on high potential female-founded startups, hand picked by Angel Academe's extensive, female-focused angel network. Register to download the brochure.
Related Articles
About the author
Syndicate Room
Syndicate Room|
Syndicate Room is authorised and regulated by the Financial Conduct Authority.
Featured Articles
Risk warning: Please click here to read the full risk warning.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
General enquiries

Please note: our office hours are weekdays, 9.30am - 5.30pm.